We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Shares of Advanced Micro (AMD) Rally on New Intel Licensing Deal
On Tuesday, shares of Advanced Micro Devices (AMD - Free Report) are rallying, up about 7.4% in midday trading after tech site Fudzilla reported that Intel (INTC - Free Report) has agreed to license its graphics chips after its deal with Nvidia (NVDA - Free Report) expired.
Intel’s deal with Nvidia ended on March 17, 2017. The two companies apparently disagreed over licensing the nForce chipset—a motherboard chipset created by Nvidia—which resulted in a $1.5 billion settlement that Intel agreed to pay for five years, said Fudzilla.
While the report was short on detail, Fudzilla did say that the agreement will now allow Intel to access AMD’s graphics Intellectual Properties, as well as most things dealing with AMD’s Radeon technology. It is still unclear, however, when the deal will be formally announced.
Over the past year, AMD has gained over 211%, and this deal with Intel will likely boost its value even more. AMD is currently a #3 (Hold) on the Zacks Rank, with a VGM score of ‘C.’
Advanced Micro Devices, Inc. Price and Consensus
Advanced Micro Devices, Inc. Price and Consensus | Advanced Micro Devices, Inc. Quote
5 Trades That Could Profit "Big-League" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today, Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>